| P2093 | author name string | Xin Li | |
| | Qi Dong | |
| | Jianping Zhou | |
| | Ming Dong | |
| | Weiwei Sheng | |
| P2860 | cites work | Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer | Q24802941 |
| | Recent developments in targeting carbonic anhydrase IX for cancer therapeutics | Q27013023 |
| | Carbonic anhydrase in human pancreas: hypotheses for the pathophysiological roles of CA isozymes | Q28140370 |
| | Differential expression of cytoplasmic carbonic anhydrases, CA I and II, and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors | Q28202361 |
| | Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 |
| | The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells | Q30439216 |
| | Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer | Q33591673 |
| | Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract | Q34378663 |
| | Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma | Q34688574 |
| | Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro | Q35051535 |
| | Molecular markers of pancreatic cancer: development and clinical relevance | Q37081461 |
| | Carbonic anhydrase IX as a target for designing novel anticancer drugs. | Q37972922 |
| | Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells. | Q39697199 |
| | Differential mucin gene expression in human pancreatic and colon cancer cells | Q41679123 |
| | Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy | Q42111675 |
| | Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors | Q42735938 |
| | Expression of carbonic anhydrase IX in human pancreatic cancer | Q44611997 |
| | Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. | Q45190009 |
| | Development and characterization of gemcitabine-resistant pancreatic tumor cells. | Q46971449 |
| | Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes. | Q53576683 |
| | Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma. | Q54411525 |
| | The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma. | Q54759655 |
| | p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. | Q54792214 |
| | Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents? | Q58863328 |
| P433 | issue | 5 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 536-543 | |
| P577 | publication date | 2012-10-22 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer | |
| P478 | volume | 107 | |